Related Experiment Video
Updated: Jul 20, 2026

05:52
Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
Published on: September 27, 2019
Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes
Matthias W Laschke1, Yves Harder, Michaela Amon
1Institute for Clinical and Experimental Surgery, University of Saarland, Homburg, Germany. matthias.laschke@uniklinik-saarland.de
Tissue Engineering
|September 14, 2006
Summary
Achieving functional three-dimensional (3D) tissue constructs requires effective vascularization. Current methods for stimulating blood vessel growth are insufficient, necessitating new strategies for rapid tissue vascularization.
Area of Science:
- Tissue Engineering
- Biomaterials Science
- Regenerative Medicine
Background:
- Long-term function of three-dimensional (3D) tissue constructs is critically dependent on adequate vascularization post-implantation.
- Research in tissue engineering extensively analyzes angiogenesis to understand and overcome vascularization challenges.
- Recent advancements include sophisticated in vivo models like the chorioallantoic membrane and dorsal skinfold chamber for detailed analysis of angiogenic dysfunction.
Purpose of the Study:
- To review current strategies for achieving vascularization in engineered tissues.
- To highlight the limitations of existing techniques in promoting rapid and sufficient blood vessel development.
- To propose future research directions for improving vascularization in tissue constructs.
Main Methods:
- Modification of scaffold biomaterial properties.
- Stimulation of blood vessel development using growth factors and slow-release devices (microspheres).
- Engineering microvascular networks using endothelial cells, stem cells, or arteriovenous shunt loops.
Main Results:
- Current techniques are insufficient for rapid vascularization, hindering adequate cellular oxygen supply.
- Existing approaches include scaffold modification, growth factor delivery, and cell-based engineering.
- In vivo models aid in analyzing angiogenic dysfunction and engraftment failure.
Conclusions:
- Future research must focus on creating pre-vascularized 3D tissue constructs in vitro.
- Co-stimulation of angiogenesis and parenchymal cell proliferation is a promising in situ engineering strategy.
- Developing rapid vascularization techniques is crucial for successful tissue construct implantation and function.
Related Concept Videos
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

